Fundraising Fox

Adele C. Oliva

Investor

Founding Partner at 1315 Capital · Board director at Sprout2 · Board director at TELA Bio · Board director at NovaSom

Philadelphia

About

Adele C. Oliva is a healthcare investor with more than 20 years of experience who founded 1315 Capital in 2014 to focus on healthcare growth equity and buyouts. She previously joined Quaker Partners in 2007 to build out their growth-stage investing practice and earlier served as Co-Head of US Healthcare at Apax Partners across Silicon Valley and Manhattan. She began her career at CoreStates and Baxter Healthcare, entered private equity as a Kauffman Fellow, and holds a BSc from St. Joseph's University and an MBA from Cornell University.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthHealthtechMedical Devices

Board director at Sprout2

Intro paths

In turn, Adele can intro founders to Sprout2's investors below.

Board director at TELA Bio

Intro paths

In turn, Adele can intro founders to TELA Bio's investors below.

Co-founders at TELA Bio

AK
Antony KoblishExecutive Officer, Director

Board director at NovaSom

Intro paths

In turn, Adele can intro founders to NovaSom's investors below.

Experience

  1. 1315 CapitalFounding Partnercurrent2014 — presentPhiladelphia, PA
  2. Quaker PartnersManaging Partnercurrent2007 — presentPhiladelphia, PA
  3. Apax PartnersCo-Head of US Healthcare2005 — 2007New York, NY
  4. Apax PartnersPartner2000 — 2007Menlo Park, CA/New York, NY
  5. Apax PartnersPrincipal, Sr. Associate, Associate1997 — 2000Menlo Park, CA
  6. Baxter HealthcareMarket Manager-Sales, Marketing & Business Development, Cardiovascular Group1994 — 1997Irvine, CA
  7. Baxter HealthcareSenior Product Manager, I.V.Systems Division1993 — 1994Round Lake, IL
  8. CoreStates Financial Corp.Financial Analyst, Senior Financial Analyst, Commercial Lending Officer1988 — 1991Philadelphia, PA

Skills & more

Alternative Investments1Private Equity1Venture CapitalHealthcareCorporate DevelopmentMergers & AcquisitionsM&A experienceDue DiligenceRestructuringEmerging MarketsAngel InvestingStart-ups
+9 moreValuationIPOAcquisition IntegrationLeveraged FinanceCorporate FinanceEntrepreneurshipStrategyBusiness ValuationInvestment Banking

From Adele's professional profile.

Deals · 6

Greenbrook TMSBoard seat

via 1315 Capital · filed Jul 2022 · $15.7M raise

NovaSomBoard seat

via 1315 Capital · filed Jun 2019 · $7.5M raise

Encore DermatologyBoard seat

via 1315 Capital · filed Apr 2019 · $41.2M raise

Sprout2Board seat

via 1315 Capital · filed Jan 2018 · $6.6M raise

ColorescienceBoard seat

via 1315 Capital · filed Jul 2017 · $16M raise

TELA BioBoard seat

via 1315 Capital · filed Jan 2017 · $7.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

3B ScientificAscent Healthcare SolutionsEKR TherapeuticsESP PharmaEsprit PharmaGenoptixHomestead Smart Health PlansInnovative HealthmiraDryOnkos SurgicalOnkos SurgicalPrecision DermatologyPrometheus LabsSkinMedica

Sources: the firm's website · SEC Form D filings.

Colleagues at 1315 Capital

Frequently asked questions

Who is Adele C. Oliva?
Adele C. Oliva is a healthcare investor with more than 20 years of experience who founded 1315 Capital in 2014 to focus on healthcare growth equity and buyouts. She previously joined Quaker Partners in 2007 to build out their growth-stage investing practice and earlier served as Co-Head of US Healthcare at Apax Partners across Silicon Valley and Manhattan. She began her career at CoreStates and Baxter Healthcare, entered private equity as a Kauffman Fellow, and holds a BSc from St. Joseph's University and an MBA from Cornell University.
Where does Adele C. Oliva work?
Adele C. Oliva is Founding Partner at 1315 Capital and Board director at Sprout2 and Board director at TELA Bio and Board director at NovaSom.
What does Adele C. Oliva invest in?
Adele C. Oliva invests in Biotech, Digital Health, Healthtech, Medical Devices.
What boards does Adele C. Oliva sit on?
Adele C. Oliva holds tracked board seats at 3B Scientific, Ascent Healthcare Solutions, Colorescience, Colorescience, EKR Therapeutics, Encore Dermatology, ESP Pharma, Esprit Pharma, Genoptix, Greenbrook TMS.
Where did Adele C. Oliva go to school?
Adele C. Oliva studied at Kauffman Fellows Program; Cornell Johnson Graduate School of Management (M.B.A., Marketing); Saint Joseph's University (B.S., Finance).

Same school

Shared employers